| Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors (NCT05235607) | Sichuan University | 2022-03-01 |
| Exercise Intervention to Improve Quality of Life in Patients With Colorectal Cancer (NCT05224518) | National Taiwan University Hospital Hsin-Chu Branch | 2022-02-21 |
| The Impact of Choice on Colorectal Cancer Screening (NCT05275530) | University of California, Los Angeles | 2022-02-21 |
| Robotic Top-down Intersphincteric Resection (NCT05961969) | National Taiwan University Hospital | 2022-02-21 |
| Evaluation of a Point-of-care Testing Instrument for Fecal Immunochemical Test (NCT05232721) | Shandong University | 2022-02-20 |
| Vitamin D Intervention and Associated Changes in the Gut Microbiome and Vitamin D Levels in Healthy Adults (NCT05387876) | Baylor University | 2022-02-14 |
| ASPIRES (Activating Cancer Survivors and Their Primary Care Providers to Increase Colorectal Cancer Screening) Study (NCT05084833) | Ann & Robert H Lurie Children's Hospital of Chicago | 2022-02-14 |
| A Stool DNA-based SDC2 Methylation Test for the Early Detection of Colorectal Cancer (NCT05255588) | Genomictree, Inc. | 2022-02-10 |
| Adenoma Detection Rate of 3D Colonoscopy (NCT05153746) | National Taiwan University Hospital | 2022-02-10 |
| Comparing Detection of Standard Colonoscopy, CAD-EYE and Combined CAD-EYE and G-EYE® Aided Colonoscopy (NCT05237310) | Smart Medical Systems Ltd. | 2022-02-02 |
| mFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer (NCT05200299) | First Affiliated Hospital of Wenzhou Medical University | 2022-02-01 |
| A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy (NCT05511051) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-02-01 |
| Hybrid-sensor Breath Analysis for Colorectal Cancer Screening (NCT05173077) | University of Latvia | 2022-02-01 |
| Safety and Immune Response to FMPV-1 (NCT05238558) | Hubro Therapeutics AS | 2022-01-31 |
| Efficacy and Safety of Tislelizumab (BGB-A317) as Neo-Adjuvant Treatment in Participants With Colorectal Cancer (NCT05116085) | BeiGene | 2022-01-26 |
| Structural Characteristics of Trunk and Limb Muscles in Cachectic Colorectal Cancer Patients (NCT06780423) | Hasselt University | 2022-01-23 |
| Implication of Genetic Variations in Long Intergenic Non-coding RNA 00511 (LINC00511) in Colorectal Cancer (NCT06534242) | Ain Shams University | 2022-01-20 |
| Study on Fatigue in Colorectal Cancer Survivors, a Lifestyle Intervention (NCT05390398) | Wageningen University | 2022-01-18 |
| SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study (NCT05010850) | SafeHeal Inc | 2022-01-17 |
| Predictive Value of Postoperative Circulating Tumor DNA Monitoring for Colorectal Cancer Recurrence (NCT06143644) | Sun Yat-sen University | 2022-01-15 |
| Perioperative Testosterone Replacement Therapy in Sarcopenic Male Colorectal Cancer Patients (NCT05367284) | London North West Healthcare NHS Trust | 2022-01-15 |
| Exercise as Medicine for People With Cancer Sweden (NCT05064670) | Karolinska Institutet | 2022-01-11 |
| Fecal Immunochemical Test for Advanced Adenoma Detection in Colorectal Cancer Screening (NCT05200611) | Shandong University | 2022-01-04 |
| Text-based Colorectal Cancer Prevention Pilot (NCT05004376) | University of Rochester | 2022-01-03 |
| Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators (NCT04722341) | Cedars-Sinai Medical Center | 2022-01-01 |
| Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research (NCT05398380) | Hospital Vall d'Hebron | 2022-01-01 |
| Immune Checkpoints in Intraabdominal Ascites Fluid (NCT04540159) | Istanbul Training and Research Hospital | 2022-01-01 |
| Systemic Neoadjuvant and Adjuvant Control by Precision Medicine in Rectal Cancer (NCT04842006) | Helsinki University Central Hospital | 2021-12-20 |
| Neutrophil-to-Lymphocite Ratio (NLR) and C-reactive Protein (CRP) as New Markers in Diagnosis and Prediction of Colorectal Cancer (NCT05129046) | Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria | 2021-12-15 |
| CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer (NCT05210283) | Exact Sciences Corporation | 2021-12-15 |
| RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to Standard Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer (NCT05862051) | Australasian Gastro-Intestinal Trials Group | 2021-12-14 |
| Real-Time Feedback (RTFB) to Improve Colonoscopy (NCT05241210) | University of Minnesota | 2021-12-13 |
| Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for Oxaliplatin (NCT05118724) | AIO-Studien-gGmbH | 2021-12-10 |
| Preserving Fertility After Colorectal Cancer Study (NCT05239338) | Andreana Holowatyj, PhD, MSCI | 2021-12-06 |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418) (NCT05008809) | Dominik Paul Modest | 2021-12-06 |
| Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer. (NCT05102110) | Origin Sciences | 2021-12-01 |
| Predictive Time-to-Event Model for Major Medical Complications After Colectomy (NCT05150548) | University of British Columbia | 2021-12-01 |
| Enhanced Monitoring for Better Recovery and Cancer Experience in Greater Manchester (NCT05099237) | Manchester University NHS Foundation Trust | 2021-12-01 |
| SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies (NCT05039944) | Sichuan Baili Pharmaceutical Co., Ltd. | 2021-11-30 |
| Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors (NCT05089266) | Shanghai Cell Therapy Group Co.,Ltd | 2021-11-30 |
| The Impact of Immune Cell Changes During the Perioperative Period on the Prognosis of Patients With Colorectal Cancer (NCT05015296) | Beijing Friendship Hospital | 2021-11-23 |
| Recurrence Rate After Endoscopic Resection of , Laterally Spreading Tumor Granular Type (LST-G) of the Colon and Rectum: Endoscopic Mucosal Resection vs. Endoscopic Submucosal Dissection (NCT06815406) | Azienda USL Reggio Emilia - IRCCS | 2021-11-18 |
| Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients (NCT04751435) | Memorial Sloan Kettering Cancer Center | 2021-11-16 |
| Anlotinib Plus Penpulimab (AK105) for Chemo-refractory Metastatic Colorectal Cancer:ALTER-C003 (NCT04970914) | Peking Union Medical College Hospital | 2021-11-05 |
| A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors (NCT05084859) | Biosplice Therapeutics, Inc. | 2021-11-03 |
| Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer (NCT04853043) | University of Utah | 2021-11-03 |
| CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers (NCT04980157) | H. Lee Moffitt Cancer Center and Research Institute | 2021-11-01 |
| Evaluating the Cologuard Test for Use in Lynch Syndrome (NCT04778566) | Geisinger Clinic | 2021-11-01 |
| Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors (NCT05187338) | Second Affiliated Hospital of Guangzhou Medical University | 2021-11-01 |
| The Effect of Education on Self-Efficacy and Adaptation to Stoma of Individuals With Stoma (NCT05531331) | Ankara University | 2021-11-01 |
| Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC (NCT02942706) | Ruijin Hospital | 2021-11-01 |
| Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing (NCT04981119) | A2 Biotherapeutics Inc. | 2021-10-29 |
| Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting (NCT04711473) | Abramson Cancer Center at Penn Medicine | 2021-10-27 |
| OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer (NCT04680260) | Karen-Lise Garm Spindler | 2021-10-25 |
| Study of PF-07263689 in Participants With Selected Advanced Solid Tumors (NCT05061537) | Pfizer | 2021-10-20 |
| Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies (NCT04847063) | National Cancer Institute (NCI) | 2021-10-19 |
| Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab (NCT05029882) | AbbVie | 2021-10-13 |
| DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease (NCT05036109) | M.D. Anderson Cancer Center | 2021-10-12 |
| A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors (NCT04853017) | Elicio Therapeutics | 2021-10-04 |
| Technical Feasibility Evaluation of Mucosal Staining During Colon Capsule Endoscopy (CCE) Procedure in Colorectal Cancer (CRC) High Risk Population, When Using MB-MMX (NCT05022719) | Medtronic - MITG | 2021-10-04 |
| Colorectal Screening Strategies in Underserved Populations (NCT05107661) | Virtua Health, Inc. | 2021-09-26 |
| Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal Cancer (NCT04262635) | Sun Yat-sen University | 2021-09-24 |
| Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors (NCT04930432) | Betta Pharmaceuticals Co., Ltd. | 2021-09-24 |
| A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors (NCT05116891) | Cantargia AB | 2021-09-22 |
| The Engaging Primary Care in Cancer Survivorship (EPICS) Study (NCT04745754) | Kaiser Permanente | 2021-09-21 |
| The PRIME-CRC Trial to Promote CRC Screening in Rural Communities (NCT04313114) | Louisiana State University Health Sciences Center Shreveport | 2021-09-20 |
| Laparoscopic Approach for Emergency Colon Resection (NCT05005117) | Joint Authority for Päijät-Häme Social and Health Care | 2021-09-17 |
| An mHealth Symptom Management Intervention for Colorectal Cancer Patients (mCOPE) (NCT04763174) | Duke University | 2021-09-15 |
| Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases (NCT04899908) | Brigham and Women's Hospital | 2021-09-15 |
| Magnetic Particle-ICG Lymph Node Mapping in Colorectal Cancer (NCT05092750) | M.D. Anderson Cancer Center | 2021-09-15 |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors (NCT05415475) | Chongqing Precision Biotech Co., Ltd | 2021-09-10 |
| Investigation of Preoperative Frailty in Elderly Patients With Colorectal Cancer and Correlation Between Preoperative Frailty and Early Postoperative Prognosis (NCT05915637) | Zunyi Medical College | 2021-09-01 |
| Three Birds With One Stone (NCT05022511) | University of Aarhus | 2021-09-01 |
| Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases (NCT04616495) | Hospital Universitario La Fe | 2021-09-01 |
| Modified MAC Diet and Gut Microbiota in CRC Patients (NCT05039060) | Korea University Anam Hospital | 2021-09-01 |
| An Additional Analysis of Data From the PARADIGM Exploratory Study (NCT02394834) in Patients With Advanced/Recurrent Colorectal Cancer (NCT05030493) | Takeda | 2021-08-31 |
| Quantitative ICG Fluorescence Angiography in Colorectal Surgery (NCT05153954) | Zealand University Hospital | 2021-08-31 |
| Assessing Effect of Withdrawal Time on Adenoma Detection Rate for Screening Colonoscopy (NCT05018325) | Washington University School of Medicine | 2021-08-30 |
| Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas (NCT04920032) | University of California, Irvine | 2021-08-26 |
| HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden. (NCT04898504) | Oslo University Hospital | 2021-08-23 |
| Follow-up After Surgery for Colorectal Cancer (NCT05656326) | Erasmus Medical Center | 2021-08-23 |
| e-Motivación: Developing and Pilot Testing an App to Improve Latinos' Screening Colonoscopy Rates (NCT04987788) | Icahn School of Medicine at Mount Sinai | 2021-08-19 |
| Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors (NCT04780217) | ImmVira Pharma Co. Ltd | 2021-08-10 |
| A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors (NCT04577963) | Hutchmed | 2021-08-09 |
| Impact of Exercise on Mitochondria in Cancer Patients. (NCT04558398) | University of Nottingham | 2021-08-05 |
| Evaluation of a New Blood-based Test to Detect Colorectal Cancer and Its Precursors (NCT04980443) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2021-08-03 |
| Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis (NCT04912258) | Fudan University | 2021-08-01 |
| Reminder Modality for CRC Screening (NCT05012007) | VA Puget Sound Health Care System | 2021-08-01 |
| PEA Promote Gastrointestinal Function Recovered After Colorectal Cancer Operation (NCT04822506) | Shanghai Yueyang Integrated Medicine Hospital | 2021-07-31 |
| Preoperative Nutritional Status and Postoperative Outcomes in Colorectal Cancer (NCT06016829) | Hacettepe University | 2021-07-25 |
| Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy (NCT04868773) | University of California, Irvine | 2021-07-16 |
| Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors (NCT04985604) | Day One Biopharmaceuticals, Inc. | 2021-07-15 |
| A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors (NCT04801095) | Wellmarker Bio | 2021-07-14 |
| The Effects of Nurse Navigation Program on Symptom Management and Psychosocial Adjustment in Colorectal Cancer Patients (NCT05571098) | Saglik Bilimleri Universitesi | 2021-07-08 |
| Establishment and Clinical Validation of New Technologies for Accurate Screening of Colorectal Cancer Based on Multi-omics (NCT04913233) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-07-01 |
| Prospective Assessment of CONECCT's Classification for Colorectal Lesions. (NCT05983315) | Hospices Civils de Lyon | 2021-07-01 |
| Efficacy of Mosapride on Recovery of Intestinal Motility After Elective Colorectal Cancer Surgery (NCT04905147) | Mahidol University | 2021-07-01 |
| Fecal Metagenomics and Metabolomics Analyses to Identify Potential Screening Biomarkers for Colorectal Polyps and Cancer in Chinese Population (NCT04947930) | Sixth Affiliated Hospital, Sun Yat-sen University | 2021-07-01 |
| Veteran Primers for CRC Screening (NCT04923646) | VA Puget Sound Health Care System | 2021-06-30 |
| A Sociolinguistic-enabled Web Application to Develop Precision Health Intervention for African Americans (NCT04705363) | University of Florida | 2021-06-29 |